Get the Stockscreener App
4.1522
0.72%
-0.0378
Orchestra Biomed Holdings Inc stock is traded at $4.1522, with a volume of 160.77K.
It is down -0.72% in the last 24 hours and up +6.67% over the past month.
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
See More
Previous Close:
$4.19
Open:
$4.16
24h Volume:
160.77K
Relative Volume:
0.53
Market Cap:
$249.10M
Revenue:
$32.72M
Net Income/Loss:
$-54.64M
P/E Ratio:
-3.682
EPS:
-1.1277
Net Cash Flow:
$-55.08M
1W Performance:
-12.42%
1M Performance:
+6.67%
6M Performance:
-6.52%
1Y Performance:
+43.94%
1-Day Range:
$4.06
$4.25
1-Week Range:
$4.06
$4.79
52-Week Range:
$2.20
$5.424
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Name
Orchestra Biomed Holdings Inc
Sector
Industry
Phone
646-343-9298
Address
150 UNION SQUARE DRIVE, NEW HOPE
Compare OBIO vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
4.16 | 258.39M | 32.72M | -54.64M | -55.08M | -1.1277 |
VRTX
Vertex Pharmaceuticals Inc
|
528.31 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
648.10 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
926.91 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.73 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.17 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Initiated | TD Cowen | Buy |
| Aug-20-25 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-20-25 | Initiated | BTIG Research | Buy |
| Jan-02-25 | Initiated | Barclays | Overweight |
| Aug-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-25-24 | Initiated | B. Riley Securities | Buy |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Feb-24-23 | Initiated | Piper Sandler | Overweight |
| Feb-07-23 | Initiated | Chardan Capital Markets | Buy |
View All
Orchestra Biomed Holdings Inc Stock (OBIO) Latest News
Form 144 Orchestra BioMed Holdings For: 1 July By Investing.com - Investing.com South Africa
Darren Sherman to sell 15,000 OBIO shares (NASDAQ: OBIO) - Stock Titan
Orchestra BioMed Joins Russell 3000 and Russell 2000 Indexes - marketscreener.com
Orchestra BioMed Holdings' Market Cap Up US$40m Following Year Of Insider Stock Buying - simplywall.st
Orchestra BioMed Holdings, Inc.(NasdaqGM: OBIO) added to Russell 2000 Index - marketscreener.com
Orchestra BioMed stock rises after Russell index addition - Investing.com
Orchestra BioMed (OBIO) Joins Russell 3000 and Russell 2000 Inde - GuruFocus
Orchestra BioMed joins Russell 2000 and 3000 indexes - Investing.com
Orchestra BioMed lands in Russell indexes tracking $12.2T - Stock Titan
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) added to Russell 2000 Growth Benchmark - marketscreener.com
Orchestra BioMed Holdings, Inc. Actuals & Estimates (NASDAQ:OBIO) - TradingView
Form 4 Orchestra Biomed Holdings Inc For: 25 June By Investing.com - Investing.com Nigeria
OBIO Forecast — Price Target — Prediction for 2027 - TradingView
Orchestra BioMed (OBIO) director awarded RSUs, options and tax shares withheld - Stock Titan
Orchestra BioMed (OBIO) director awarded RSUs and options with tax-share withholding - Stock Titan
Orchestra BioMed (OBIO) director logs RSU tax withholding and 42,553-option grant - Stock Titan
Orchestra BioMed (NASDAQ: OBIO) director receives new RSU and stock option grants - Stock Titan
Orchestra BioMed (OBIO) director receives 42,553 stock options at $4.04 strike - Stock Titan
Orchestra BioMed (OBIO) director granted RSUs, shares withheld for taxes - Stock Titan
Orchestra Biomed Holdings Inc (OBIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Orchestra BioMed shareholders approve director elections and key proposals at annual meeting By Investing.com - Investing.com Australia
Orchestra BioMed shareholders approve director elections and key proposals at annual meeting - Investing.com South Africa
Form 8K Orchestra Biomed Holdings Inc For: 23 June By Investing.com - Investing.com Nigeria
Orchestra BioMed Shareholders Approve Directors and Incentive Plan - TipRanks
Orchestra BioMed (NASDAQ: OBIO) investors approve all 2026 meeting items - Stock Titan
Orchestra BioMed Holdings (OBIO) Bounces from Support: +2.26% Gain Signals Potential RecoveryWedge Breakout - dars.gov.et
Orchestra BioMed Holdings (OBIO) Gets a Hold from BTIG - The Globe and Mail
Orchestra Biomed Holdings Inc (OBIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Institutional Confidence - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Orchestra Biomed Holdings Inc (OBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Orchestra Biomed Holdings Inc - TradingKey
OBIO Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesRevenue Recognition Risk - newsline.com
Orchestra BioMed (OBIO) Edges Higher, Testing Key Resistance Zone on Modest VolumeLow Beta Factor - newsline.com
Orchestra BioMed (NASDAQ: OBIO) CFO has shares withheld to cover RSU tax obligations - Stock Titan
Orchestra BioMed (OBIO) insider uses 6,566 shares to cover RSU taxes - Stock Titan
Orchestra BioMed Grants Equity Awards to New Employees - MyChesCo
Number of shareholders of Orchestra BioMed Holdings, Inc. – NASDAQ:OBIO - TradingView
Orchestra BioMed Holdings (OBIO) Slips 2.26% as Shares Test Support Near $3.70Chart Pattern Alerts - newsline.com
Orchestra BioMed receives $20 million from Medtronic - Investing.com
OBIO: Upcoming BackBeat and Virtue trial milestones signal strong growth and partnership-driven value - TradingView
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Insider Sell Alert: Darren Sherman Sells Shares of Orchestra Bio - GuruFocus
Insider Sell Alert: Darren Sherman Sells Shares of Orchestra BioMed Holdings Inc (OBIO) - GuruFocus
Orchestra BioMed (OBIO) director adds 5,000 shares in open-market buy - Stock Titan
Orchestra BioMed (OBIO) director Darren Sherman sells 15,000 shares under 10b5-1 plan - Stock Titan
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
Orchestra BioMed (OBIO) Rebounds: Key Levels to Watch After 2% GainPCR Moving Average - dars.gov.et
Orchestra Biomed Holdings Inc Stock (OBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orchestra Biomed Holdings Inc Stock (OBIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hochman David P | See Remarks |
Jun 01 '26 |
Buy |
3.83 |
5,000 |
19,150 |
1,064,029 |
| Sherman Darren | See Remarks |
Jun 01 '26 |
Sale |
3.87 |
15,000 |
58,050 |
1,184,327 |
0.72%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):